Hemab Therapeutics Holdings, Inc.
COAG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002114044
No open-market purchases or sales by Hemab Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; Soros Fund Management is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Hemab Therapeutics Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +56 vs. Q1 2026
- Shares held
- 36.3M
- +36.3M vs. Q1 2026
- Total value
- $1.33B
- +$1.33B vs. Q1 2026
- New holders
- 56
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COAG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $1.33B |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Hemab Therapeutics Holdings, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 7,808,627 | $286.8M | 2.49% | +7,808,627 | New |
| Novo Holdings A/S | 4,180,550 | $153.6M | 8.95% | +4,180,550 | New |
| FMR LLC | 3,697,837 | $135.8M | 0.01% | +3,697,837 | New |
| Capital International Investors | 3,603,876 | $132.4M | 0.03% | +3,603,876 | New |
| Deep Track Capital, LP | 3,602,093 | $132.3M | 1.95% | +3,602,093 | New |
| Siren, L.L.C. | 2,086,834 | $76.6M | 1.56% | +2,086,834 | New |
| Avoro Capital Advisors LLC | 1,925,150 | $70.7M | 0.63% | +1,925,150 | New |
| Bain Capital Life Sciences Investors, LLC | 1,650,000 | $60.6M | 3.60% | +1,650,000 | New |
| JPMorgan Chase & Co | 1,152,420 | $42.3M | 0.00% | +1,152,420 | New |
| Vanguard Capital Management LLC | 780,758 | $28.7M | 0.00% | +780,758 | New |
| Price T Rowe Associates Inc | 746,040 | $27.4M | 0.00% | +746,040 | New |
| Driehaus Capital Management LLC | 715,791 | $26.3M | 0.15% | +715,791 | New |
| Rock Springs Capital Management LP | 575,432 | $21.1M | 1.03% | +575,432 | New |
| Bellevue Group AG | 550,000 | $20.2M | 0.43% | +550,000 | New |
| Citadel Advisors LLC | 523,450 | $19.2M | 0.01% | +523,450 | New |
| BlackRock, Inc. | 283,833 | $10.4M | 0.00% | +283,833 | New |
| Deerfield Management Company, L.P. (Series C) | 275,000 | $10.1M | 0.11% | +275,000 | New |
| ExodusPoint Capital Management, LP | 218,287 | $8.02M | 0.07% | +218,287 | New |
| Geode Capital Management, LLC | 211,798 | $7.78M | 0.00% | +211,798 | New |
| Braidwell LP | 160,000 | $5.88M | 0.22% | +160,000 | New |
| Marshall Wace, LLP | 154,674 | $5.68M | 0.00% | +154,674 | New |
| Woodline Partners LP | 150,040 | $5.51M | 0.02% | +150,040 | New |
| Affinity Asset Advisors, LLC | 138,030 | $5.07M | 0.25% | +138,030 | New |
| Ensign Peak Advisors, Inc | 115,394 | $4.24M | 0.01% | +115,394 | New |
| Vanguard Fiduciary Trust Co | 112,499 | $4.13M | 0.00% | +112,499 | New |
| Charles Schwab Investment Management Inc | 108,236 | $3.98M | 0.00% | +108,236 | New |
| Ameriprise Financial Inc | 81,928 | $3.01M | 0.00% | +81,928 | New |
| State Street Corp | 76,900 | $2.82M | 0.00% | +76,900 | New |
| Burkehill Global Management, LP | 75,000 | $2.75M | 0.10% | +75,000 | New |
| Standard Life Aberdeen plc | 52,117 | $1.91M | 0.00% | +52,117 | New |
| Opaleye Management Inc. | 47,652 | $1.75M | 0.16% | +47,652 | New |
| UBS Group AG | 47,351 | $1.74M | 0.00% | +47,351 | New |
| Parkman Healthcare Partners LLC | 45,000 | $1.65M | 0.17% | +45,000 | New |
| Northern Trust Corp | 40,487 | $1.49M | 0.00% | +40,487 | New |
| Ghisallo Capital Management LLC | 40,000 | $1.47M | 0.03% | +40,000 | New |
| TD Asset Management Inc | 33,098 | $1.22M | 0.00% | +33,098 | New |
| Seven Grand Managers, LLC | 30,000 | $1.10M | 0.04% | +30,000 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 25,000 | $918.3K | 0.01% | +25,000 | New |
| Manufacturers Life Insurance Company, The | 18,720 | $687.6K | 0.00% | +18,720 | New |
| Gsa Capital Partners LLP | 17,661 | $649.0K | 0.04% | +17,661 | New |
| XTX Topco Ltd | 17,389 | $638.7K | 0.01% | +17,389 | New |
| Landscape Capital Management, L.L.C. | 13,183 | $484.2K | 0.03% | +13,183 | New |
| Hudson Bay Capital Management LP | 12,202 | $448.2K | 0.00% | +12,202 | New |
| Schonfeld Strategic Advisors LLC | 10,813 | $397.2K | 0.00% | +10,813 | New |
| Weiss Asset Management LP | 10,000 | $367.3K | 0.00% | +10,000 | New |
| Vanguard Portfolio Management LLC | 8,169 | $300.0K | 0.00% | +8,169 | New |
| Vanguard Global Advisers, LLC | 7,616 | $279.7K | 0.00% | +7,616 | New |
| Squarepoint Ops LLC | 6,252 | $229.6K | 0.00% | +6,252 | New |
| Two Sigma Investments, LP | 5,680 | $208.6K | 0.00% | +5,680 | New |
| Morgan Stanley | 4,078 | $149.8K | 0.00% | +4,078 | New |
| China Universal Asset Management Co., Ltd. | 3,600 | $132.2K | 0.01% | +3,600 | New |
| Citigroup Inc | 2,095 | $76.9K | 0.00% | +2,095 | New |
| Barclays PLC | 1,011 | $37.1K | 0.00% | +1,011 | New |
| Royal Bank of Canada | 248 | $9.00K | 0.00% | +248 | New |
| Jones Financial Companies LLLP | 3 | $97 | 0.00% | +3 | New |
| Tower Research Capital LLC (TRC) | 1 | $37 | 0.00% | +1 | New |